Position in CTMX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$299,361
-$3,347,437 QoQ
Shares Held
63,694
-92.6% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CTMX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $731,256,203 across 167 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,664,999 | $188,744,286 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,440 | $98,170,137 | |
| 3 | IMCR |
Immunocore Holdings plc
|
1,209,894 | $38,414,134 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
|
591,686 | $23,146,756 | |
| 5 | EXEL |
Exelixis, Inc.
|
421,444 | $22,930,768 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
42,122 | $20,923,261 | |
| 7 | TBPH |
Theravance Biopharma, Inc.
|
1,174,910 | $19,973,470 | |
| 8 | PRTA |
Prothena Corp Public Ltd Co
|
2,010,645 | $19,684,214 |
All Filings in CTMX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $299,361 | 63,694 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,646,798 | 856,056 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $2,085,382 | 653,725 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,534,471 | 1,557,036 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $2,056,846 | 3,234,035 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $3,231,157 | 3,137,046 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $3,659,172 | 3,100,994 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,328,854 | 2,728,569 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $5,866,009 | 2,690,830 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $4,101,594 | 2,646,190 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,413,585 | 2,646,190 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,564,150 | 2,653,576 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $4,006,899 | 2,653,576 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $4,245,721 | 2,653,576 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,847,685 | 2,653,576 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,365,783 | 1,839,226 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $2,363,235 | 885,107 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $1,780,591 | 411,222 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $3,568,039 | 700,990 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $6,641,049 | 1,049,139 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $7,320,008 | 946,961 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $4,505,679 | 687,890 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $3,871,729 | 582,215 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $2,465,671 | 295,999 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $2,087,643 | 272,183 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||